INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $73,000 | -57.3% | 42,393 | -11.1% | 0.00% | – |
| Q1 2022 | $171,000 | -17.0% | 47,672 | +15.7% | 0.00% | – |
| Q4 2021 | $206,000 | -30.2% | 41,197 | 0.0% | 0.00% | – |
| Q3 2021 | $295,000 | -40.6% | 41,197 | -22.9% | 0.00% | -100.0% |
| Q2 2021 | $497,000 | +29.1% | 53,434 | +28.8% | 0.00% | – |
| Q1 2021 | $385,000 | -23.3% | 41,500 | -26.6% | 0.00% | -100.0% |
| Q4 2020 | $502,000 | +206.1% | 56,550 | +300.2% | 0.00% | – |
| Q3 2020 | $164,000 | -60.0% | 14,131 | -7.2% | 0.00% | -100.0% |
| Q2 2020 | $410,000 | +419.0% | 15,220 | +33.1% | 0.00% | – |
| Q4 2016 | $79,000 | – | 11,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |